LoadingLoadingLoading32 funds hold it.Insiders net selling.
Net selling: insiders sold $354.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 29, 2026
Financial period
Q3 2026
Earnings per share
$1.36 expected
Revenue
$1.15B expected
Company adjusted EPS: $1.62. Company and provider EPS differ; bases unknown.
FY 2026 guidance
$4.64B to $4.66B
No comparable estimate
Estimates as of Nov 4, 2026
EPS expected
$1.51 to $1.56
Revenue expected
16 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 27, 2026Reported Oct 29, 2026 | $1.44est. $1.36 | +6.08%beat | $1.13Best. $1.15B-2.06% | +4.2%from $1.08B |
| Jun 28, 2026Reported Jul 30, 2026 | $1.35Company GAAP | Not comparableDifferent EPS measure | $1.16BSEC filing | +9.4%from $1.06B |
| Mar 29, 2026Reported Apr 30, 2026 | $1.15est. $1.05 | +9.03%beat | $1.09BSEC filing | +4.8%from $1.04B |
| Dec 31, 2025Reported Feb 5, 2026 | $1.35est. $1.23 | +9.69%beat | $1.16BAlpha Vantage | +5.1%from $1.10B |
| Sep 28, 2025Reported Oct 30, 2025 | $1.34est. $1.17 | +14.53%beat | $1.08BSEC filing | +0.4%from $1.08B |
| Jun 29, 2025Reported Jul 31, 2025 | $1.19est. $1.01 | +17.82%beat | $1.06BSEC filing | -4.8%from $1.11B |
| Mar 30, 2025Reported May 8, 2025 | $0.97est. $0.94 | +3.19%beat | $1.04BSEC filing | -3.3%from $1.08B |
| Dec 31, 2024Reported Feb 6, 2025 | $0.86est. $0.92 | -6.52%miss | $1.10BAlpha Vantage | -1.6%from $1.12B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.16B | $1.09B | $1.16B | $1.13B |
| Cost of what it sold | $382.0M | $370.0M | $389.0M | $299.0M |
| Gross profit | $778.0M | $721.0M | $770.0M | $830.0M |
| What it spent | ||||
| Research and development | $238.0M | $240.0M | $252.0M | $244.0M |
| Sales and admin | $283.0M | $272.0M | $273.0M | $281.0M |
| Total operating expenses | $521.0M | $512.0M | $525.0M | $525.0M |
| What was left | ||||
| Operating profit | $257.0M | $209.0M | $245.0M | $305.0M |
| Interest on debt | $26.0M | $24.0M | — | $24.0M |
| Profit before tax | $378.0M | $157.0M | $260.0M | $264.0M |
| Tax | $44.0M | $23.0M | $53.0M | $44.0M |
| Net profit | $334.0M | $134.0M | $207.0M | $220.0M |
| EBITDA | $471.0M | $250.0M | $330.0M | $335.0M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Illumina, Inc. (ILMN) Selected for Singapore Study of Around 450,000 People
Leans bullishNov 3A Singapore study could read the genetic code of about 450,000 people
BullishNov 3Illumina selected to help bring precision medicine into everyday healthcare in Singapore
BullishNov 3Illumina Inc. stock underperforms Monday when compared to competitors
BearishNov 2What Sent Illumina Stock Lower?
Leans bearishNov 1Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026
BullishOct 30Illumina Stock Slumps Despite Full-Year Guidance Raise, Solid Q3 Results
Leans bearishOct 30Illumina, Inc. (ILMN) Seasonal Returns Chart - Yahoo Finance
Leans bearishOct 2934 macro signals shaping ILMN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
